Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
The Lancet. Microbe|February 1, 2021
Multiplex assays for the identification of serological signatures of SARS-CoV-2 infection: an antibody-based diagnostic and machine learning studyJason Rosado, Stéphane Pelleau, Charlotte Cockram, et al.
JCI Insight|May 30, 2023
Qualitative monitoring of SARS-CoV-2 mRNA vaccination in humans using droplet microfluidicsMatteo Broketa, Aurélien Sokal, Michael Mor, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 22, 2023
Estimated protection against COVID-19 based on predicted neutralisation titres from multiple antibody measurements in a longitudinal cohort, France, April 2020 to November 2021Tom Woudenberg, Laurie Pinaud, Laura Garcia, et al.
Plos Pathogens|March 1, 2021
Correction: Repertoire characterization and validation of gB-specific human IgGs directly cloned from humanized mice vaccinated with dendritic cells and protected against HCMVSebastian J Theobald, Christoph Kreer, Sahamoddin Khailaie, et al.
Plos Pathogens|July 16, 2020
Repertoire characterization and validation of gB-specific human IgGs directly cloned from humanized mice vaccinated with dendritic cells and protected against HCMVSebastian J Theobald, Christoph Kreer, Sahamoddin Khailaie, et al.
Science Translational Medicine|December 3, 2025
A vaccine targeting human IgE induces long-term protection against anaphylaxis in humanized miceEva Conde, Emma Lamanna, Aurélie Mougel, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 2, 2021
Prior infection by seasonal coronaviruses, as assessed by serology, does not prevent SARS-CoV-2 infection and disease in children, France, April to June 2020Isabelle Sermet-Gaudelus, Sarah Temmam, Christèle Huon, et al.
The Journal of Experimental Medicine|June 15, 2022
Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2Cyril Planchais, Ignacio Fernández, Timothée Bruel, et al.
The Journal of Infectious Diseases|July 20, 2021
Kinetics of the Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and Serological Estimation of Time Since InfectionStéphane Pelleau, Tom Woudenberg, Jason Rosado, et al.
Science Translational Medicine|August 21, 2020
A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populationsLudivine Grzelak, Sarah Temmam, Cyril Planchais, et al.
Pageof 9